icon-folder.gif   Conference Reports for NATAP  
 
  HIV Glasgow 2026
8-11 November
Back grey_arrow_rt.gif
 
 
 
Higher Persistence on Twice-yearly Lenacapavir Versus Daily F/TDF for PrEP in the UK and France in the PURPOSE 5 Study
 
 
  Glasgow 2026 Nov 8-11

1108261copy

1108262copy

1108263copy

1108264copy

1108265copy

1108266copy

1108267copy

1108268copy

1108269copy